Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksDiaceutics Regulatory News (DXRX)

Share Price Information for Diaceutics (DXRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.00
Bid: 102.00
Ask: 104.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.961%)
Open: 103.00
High: 103.00
Low: 103.00
Prev. Close: 103.00
DXRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Suspension - Diaceutics PLC

13 Mar 2023 07:30

RNS Number : 7201S
AIM
13 March 2023
 

NOTICE

 

13/03/2023 7:30am

 

TEMPORARY SUSPENSION OF TRADING ON AIM

 

DIACEUTICS PLC

 

At the request of the company, trading on AIM for the under-mentioned securities has been temporarily suspended from 13/03/2023 7:30am, pending an announcement.

 

ORDINARY SHARES OF GBP0.002 EACH, FULLY PAID (BJQTGV6) (GB00BJQTGV64)

 

If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0) 20 7710 7600.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
EXCJJMFTMTJBMMJ
Date   Source Headline
9th Apr 20247:00 amRNSAppointment of Amie Mc Neice as VP of Marketing
5th Apr 20241:40 pmRNSBlock Listing Return
3rd Apr 20247:00 amRNSPDMR Shareholding/Share Incentive Plan
2nd Apr 20247:00 amRNSDirector/PDMR/PCA Shareholding & TR1
21st Mar 20247:00 amRNSSignificant upgrade to Diaceutics' DXRX platform
19th Mar 20247:00 amRNSDiaceutics forms landmark industry Forum
7th Mar 20247:00 amRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSPDMR Shareholding / SIP and TVR
27th Feb 20247:00 amRNSExpanded lab network and data capabilities
14th Feb 20241:00 pmRNSDiaceutics PLC - Strategic alliance with KPMG
5th Feb 20247:00 amRNSAppointment of VP, Scientific & Medical Services
1st Feb 202412:31 pmRNSPDMR Shareholding/Share Incentive Plan and TVR
30th Jan 20247:00 amRNSDiaceutics PLC – Trading Update
25th Jan 20241:16 pmRNSExercise of Warrant & Total Voting Rights
19th Jan 20247:00 amRNSDiaceutics PLC – Financial Calendar Update
29th Dec 20231:18 pmRNSPDMR Shareholding/Share Incentive Plan
30th Nov 202312:59 pmRNSPDMR Shareholding/Share Incentive Plan and TVR
30th Nov 20237:00 amRNSDiaceutics to attend Stifel Conference in NYC
21st Nov 202311:13 amRNSNotification of Major Holdings
31st Oct 202312:38 pmRNSPDMR Shareholding/SIP & Total Voting Rights
11th Oct 20231:47 pmRNSPDMR Shareholding/Share Incentive Plan and TVR
2nd Oct 20233:59 pmRNSBlock Listing Application to AIM
29th Sep 202311:19 amRNSHolding(s) in Company
26th Sep 20237:00 amRNSDiaceutics PLC – Half Year Results
26th Sep 20237:00 amRNSDiaceutics PLC - Planned CEO Transition
21st Sep 20232:37 pmRNSDiaceutics PLC – Directorate Changes
7th Sep 20237:00 amRNSAttending 10th Annual HealthTech Investment Forum
5th Sep 20237:00 amRNSNotice of Interim Results and Presentations
30th Aug 20232:56 pmRNSPDMR Shareholding/Share Incentive Plan
29th Aug 20237:00 amRNSDiaceutics launches daily alerts for DXRX platform
4th Aug 20237:00 amRNSCanaccord Genuity 43rd Annual Growth Conference
31st Jul 20233:19 pmRNSPDMR Shareholding/Share Incentive Plan
25th Jul 20237:00 amRNSTrading Update and Notice of Results
29th Jun 202312:07 pmRNSPDMR Shareholding/Share Incentive Plan
6th Jun 20237:00 amRNSPurchase and Sale of Shares and PDMR Shareholdings
5th Jun 20237:00 amRNSUSD 10.1 million multi-year enterprise engagement
31st May 20235:13 pmRNSPDMR Shareholding/Share Incentive Plan
19th May 202310:16 amRNSIssue of Share Options/PDMR Shareholdings
18th May 202311:46 amRNSResults of Annual General Meeting
11th May 20236:22 pmRNSPDMR Shareholdings
4th May 202310:34 amRNSPDMR shareholdings
28th Apr 20236:03 pmRNSPDMR Shareholding/Share Incentive Plan
26th Apr 20235:03 pmRNSPDMR Shareholding
25th Apr 20235:45 pmRNSNotice of AGM and Posting of Annual Report
17th Apr 20237:00 amRNSFinal Results
3rd Apr 20232:43 pmRNSPDMR Shareholding / Share Incentive Plan
20th Mar 20237:00 amRNSNotice of Results and Presentations
13th Mar 202310:15 amRNSRestoration - Diaceutics PLC
13th Mar 202310:12 amRNSFurther update regarding Silicon Valley Bank
13th Mar 20237:30 amRNSSuspension - Diaceutics PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.